Bla

Edit

uniQure Announces Plan for BLA Submission for AMT-130 in Huntington’s Disease

Nasdaq Globe Newswire 17 Jun 2026

~ 3-year analysis from the Phase I/II study can serve as the primary basis of a Biologics License Application for accelerated approval with FDA ~ ... .

Edit

uniQure Announces Plan for BLA Submission for AMT-130 in Huntington’s Disease (Form 8-K) (uniQure NV)

Public Technologies 17 Jun 2026

uniQure Announces Plan for BLA Submission for AMT-130 in ... ~ Company intends to submit the BLA in third quarter of 2026 ~ ... The Company intends to submit the BLA in the third quarter of 2026.

Edit

Inhibrx Announces U.S. FDA Acceptance of BLA for Ozekibart in Patients with Conventional Chondrosarcoma

Missoulian 16 Jun 2026

No filing review issues identified by FDA with PDUFA goal date set for April 14, 2027If Approved, Ozekibart Would Be the First and Only FDA-Approved Treatment for Unresectable or Metastatic Conventional Chondrosarcoma ... .

Edit

Inhibrx Announces U.S. FDA Acceptance of BLA for Ozekibart in Patients with Conventional Chondrosarcoma (Form 8-K) (Inhibrx Biosciences Inc)

Public Technologies 15 Jun 2026

FDA Acceptance of BLA for Ozekibart in Patients with Conventional Chondrosarcoma ... Food and Drug Administration (FDA) has accepted for filing its Biologics License Application (BLA) seeking approval of ...

Edit

US blocks Pakistan, China's bid at UNSC to blacklist BLA, Majeed Brigade

The Times of India 11 Jun 2026

The US has blocked a joint bid by Pakistan and China at the UN Security Council to designate the Balochistan Liberation Army (BLA) and the Majeed Brigade as a terrorist entity.Islamabad and Beijing ...

Edit

US blocks Pakistan, China’s bid at UNSC to blacklist BLA, Majeed Brigade

Deccan Herald 10 Jun 2026

The US has blocked a joint bid by Pakistan and China at the UN Security Council to designate ...

Edit

US blocks China and Pakistan's bid to have UNSC designate BLA, Majeed Brigade as terrorist organisations

Hindustan Times 10 Jun 2026

. World News ....

Edit

MEDIPOST Secures FDA Agreement on Single Pivotal Phase 3 Study with Confirmatory Evidence BLA Filing ...

Williston Observer 04 Jun 2026

....

Edit

MEDIPOST Secures FDA Agreement on Single Pivotal Phase 3 Study with Confirmatory Evidence BLA Filing Strategy for CARTISTEM® in the U.S.

PR Newswire 04 Jun 2026

and Canada. By securing this agreement, MEDIPOST seeks to accelerate CARTISTEM®'s U.S ... clinical development timeline and clinical development costs with an earlier BLA filing timepoint, which could facilitate an expedited commercial entry to the U.S ... .

Edit

Replimune Announces Planned RP1 BLA Resubmission Following Productive Discussion with FDA

Nasdaq Globe Newswire 29 May 2026

Food and Drug Administration (FDA), the Company and the FDA have aligned on a path forward for resubmission ...

Edit

Replimune Announces Planned RP1 BLA Resubmission Following Productive Discussion with FDA (Form 8-K) (Replimune Group Inc)

Public Technologies 29 May 2026

Replimune Announces Planned RP1 BLA Resubmission Following Productive Discussion with FDA ... The company will resubmit the RP1 BLA in the coming days. The FDA has indicated it will treat the BLA ...

Edit

Zenas BioPharma Announces Submission of Biologics License Application (BLA) to U.S. FDA for Obexelimab in IgG4-RD

Nasdaq Globe Newswire 28 May 2026

- BLA submission based on positive results from Phase 3 INDIGO trial - ... .

Edit

Zenas BioPharma Announces Submission of Biologics License Application (BLA) to U.S. FDA for

Hastings Tribune 28 May 2026

- BLA submission based on positive results from Phase 3 INDIGO trial - ... .

Edit

Quetta railway bombing and the expansion of Baloch insurgency in Pakistan

Blitz 27 May 2026

On May 24, 2026, there was a suicide car bomb attack by the Baloch Liberation Army (BLA) near the railway area in Quetta, Balochistan ... The BLA claimed responsibility for these attacks, stating.

Edit

BLA claims attack on Pakistan military train near Quetta killed 82 soldiers

India Today 26 May 2026

BLA claims attack on Pakistan military train near Quetta killed 82 soldiers ... .

Podcasts:

Latest News for: bla

uniQure Announces Plan for BLA Submission for AMT-130 in Huntington’s Disease

uniQure Announces Plan for BLA Submission for AMT-130 in Huntington’s Disease (Form 8-K) (uniQure NV)

Inhibrx Announces U.S. FDA Acceptance of BLA for Ozekibart in Patients with Conventional Chondrosarcoma

Inhibrx Announces U.S. FDA Acceptance of BLA for Ozekibart in Patients with Conventional Chondrosarcoma (Form 8-K) (Inhibrx Biosciences Inc)

US blocks Pakistan, China's bid at UNSC to blacklist BLA, Majeed Brigade

US blocks Pakistan, China’s bid at UNSC to blacklist BLA, Majeed Brigade

US blocks China and Pakistan's bid to have UNSC designate BLA, Majeed Brigade as terrorist organisations

MEDIPOST Secures FDA Agreement on Single Pivotal Phase 3 Study with Confirmatory Evidence BLA Filing ...

MEDIPOST Secures FDA Agreement on Single Pivotal Phase 3 Study with Confirmatory Evidence BLA Filing Strategy for CARTISTEM® in the U.S.

Replimune Announces Planned RP1 BLA Resubmission Following Productive Discussion with FDA

Replimune Announces Planned RP1 BLA Resubmission Following Productive Discussion with FDA (Form 8-K) (Replimune Group Inc)

Zenas BioPharma Announces Submission of Biologics License Application (BLA) to U.S. FDA for Obexelimab in IgG4-RD

Zenas BioPharma Announces Submission of Biologics License Application (BLA) to U.S. FDA for

Quetta railway bombing and the expansion of Baloch insurgency in Pakistan

BLA claims attack on Pakistan military train near Quetta killed 82 soldiers

Article Search

EXPLORE WN.com